COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies

References

• Chari A, Samur MK, Martinez-Lopez J, et al. Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the international myeloma society data set. Blood. 2020;136(26):3033–3040.
   PubMed Web of Science ®Google Scholar
• Girmenia C, Gentile G, Micozzi A, et al. COVID-19 in patients with hematologic disorders undergoing therapy: perspective of a large referral hematology center in Rome. Acta Haematol. 2020;143(6):574–582.
   PubMed Web of Science ®Google Scholar
• Ferrara F, Zappasodi P, Roncoroni E, et al. Impact of covid-19 on the treatment of acute myeloid leukemia. Leukemia. 2020;34(8):2254–2256.
   PubMed Web of Science ®Google Scholar
• Cattaneo C, Daffini R, Pagani C, et al. Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19. Cancer. 2020;126(23):5069–5076.
   PubMed Web of Science ®Google Scholar
• Vijenthira A, Gong IY, Fox TA, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136(25):2881–2892.
   PubMed Web of Science ®Google Scholar
• Christopeit M, Reichard M, Niederwieser C, et al. Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection. Bone Marrow Transplant. 2021;56(6):1478–1481.
   PubMed Web of Science ®Google Scholar
• Sharma A, Bhatt NS, St Martin A, et al. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. 2021;8(3):e185–e193.
   PubMed Web of Science ®Google Scholar
• Roedl K, Heidenreich S, Pfefferle S, et al. Viral dynamics of SARS-CoV-2 in critically ill allogeneic hematopoietic stem cell transplant recipients and immunocompetent patients with COVID-19. Am J Respir Crit Care Med. 2021;203(2):242–245.
   PubMed Web of Science ®Google Scholar
• Ghandili S, Pfefferle S, Roedl K, et al. Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients. Blood Adv. 2020;4(23):5936–5941.
   PubMed Web of Science ®Google Scholar
• Yousuf HM, Englund J, Couch R, et al. Influenza among hospitalized adults with leukemia. Clin Infect Dis. 1997;24(6):1095–1099.
   PubMed Web of Science ®Google Scholar
• Gabutti G, De Motoli F, Sandri F, et al. Viral respiratory infections in hematological patients. Infect Dis Ther. 2020;9(3):495–510.
   PubMed Web of Science ®Google Scholar
• Martino R, Ramila E, Rabella N, et al. Respiratory virus infections in adults with hematologic malignancies: a prospective study. Clin Infect Dis. 2003;36(1):1–8.
   PubMed Web of Science ®Google Scholar
• Vilar-Compte D, Shah DP, Vanichanan J, et al. Influenza in patients with hematological malignancies: experience at two comprehensive cancer centers. J Med Virol. 2018;90(1):50–60.
   PubMed Web of Science ®Google Scholar
• Chemaly RF, Torres HA, Aguilera EA, et al. Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clin Infect Dis. 2007;44(7):964–967.
   PubMed Web of Science ®Google Scholar
• Brehm TT, van der Meirschen M, Hennigs A, et al. Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza. Sci Rep. 2021;11(1):5803.
   PubMed Web of Science ®Google Scholar
• Piroth L, Cottenet J, Mariet AS, et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med. 2021;9(3):251–259.
   PubMed Web of Science ®Google Scholar
• Zayet S, Kadiane-Oussou NJ, Lepiller Q, et al. Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster. Microbes Infect. 2020;22(9):481–488.
   PubMed Web of Science ®Google Scholar
• Pormohammad A, Ghorbani S, Khatami A, et al. Comparison of influenza type A and B with COVID-19: a global systematic review and meta-analysis on clinical, laboratory and radiographic findings. Rev Med Virol. 2021;31(3):e2179.
   PubMed Web of Science ®Google Scholar
• Weisel KC, Morgner-Miehlke A, Petersen C, et al. Implications of SARS-CoV-2 infection and COVID-19 crisis on clinical cancer care: report of the University Cancer Center Hamburg. Oncol Res Treat. 2020;43(6):307–313.
   PubMed Web of Science ®Google Scholar
• Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533.
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2020. Report of the WHO–China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available from: <https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report>
   Google Scholar
• Garcia-Suarez J, de la Cruz J, Cedillo A, et al. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study. J Hematol Oncol. 2020;13(1):133.
   PubMed Web of Science ®Google Scholar
• Paget J, Spreeuwenberg P, Charu V, et al. Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMOR project. J Glob Health. 2019;9:020421.
   PubMed Web of Science ®Google Scholar
• Lyman GH, Abella E, Pettengell R. Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: a systematic review. Crit Rev Oncol Hematol. 2014;90(3):190–199.
   PubMed Web of Science ®Google Scholar
• Dale DC. How I diagnose and treat neutropenia. Curr Opin Hematol. 2016;23:1–4.
   PubMed Web of Science ®Google Scholar
• Escrihuela-Vidal F, Laporte J, Albasanz-Puig A, et al. Update on the management of febrile neutropenia in hematologic patients. Rev Esp Quimioter. 2019;32 (Suppl 2):55–58.
   PubMed Web of Science ®Google Scholar
• Bow E. Risk assessment of adults with chemotherapy-induced neutropenia. Available from: https://www.uptodate.com/contents/risk-assessment-of-adults-with-chemotherapy-induced-neutropenia. 2021
   Google Scholar
• Fouad R, Musa S, Sabry D, et al. Analysis of clinical and virologic features in hepatitis B e antigen (HbeAg)-negative and HbeAg-positive Egyptian chronic hepatitis B patients. Afr Health Sci. 2020;20(2):649–655.
   PubMed Web of Science ®Google Scholar
• Van Oekelen O, Gleason CR, Agte S, et al. Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma. Cancer Cell. 2021;39(8):1028–1030.
   PubMed Web of Science ®Google Scholar
• Herishanu Y, Avivi I, Aharon A, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021;137(23):3165–3173.
   PubMed Web of Science ®Google Scholar
• Pimpinelli F, Marchesi F, Piaggio G, et al. Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution. J Hematol Oncol. 2021;14(1):81.
   PubMed Web of Science ®Google Scholar